Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.
about
What is the Minimal Surgery for Papillary Thyroid Carcinoma?Radioiodine Remnant Ablation: A Critical ReviewManagement Guidelines for Children with Thyroid Nodules and Differentiated Thyroid CancerThe surgical approach to managing differentiated thyroid cancerNomenclature Revision for Encapsulated Follicular Variant of Papillary Thyroid Carcinoma: A Paradigm Shift to Reduce Overtreatment of Indolent Tumors2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid CancerThyroglossal duct remnant carcinoma: beyond the Sistrunk procedure.The acceleration in papillary thyroid cancer incidence rates is similar among racial and ethnic groups in the United States.Reproductive outcomes and nononcologic complications after radioactive iodine ablation for well-differentiated thyroid cancer.Low versus high radioiodine activity to ablate the thyroid after thyroidectomy for cancer: a meta-analysis of randomized controlled trials.Adjuvant radioactive iodine therapy is associated with improved survival for patients with intermediate-risk papillary thyroid cancerTrends in imaging after diagnosis of thyroid cancer.Diagnosis and treatment of patients with thyroid cancer.Use of radioactive iodine for thyroid cancer.The role of clinicians in determining radioactive iodine use for low-risk thyroid cancer.Long-term survival in young women: hazards and competing risks after thyroid cancer.To treat or not to treat: the role of adjuvant radioiodine therapy in thyroid cancer patients.Disease severity and radioactive iodine use for thyroid cancerFactors that influence radioactive iodine use for thyroid cancer.Differentiated thyroid cancer: feasibility of loboisthmectomy in an endemic region.Lymph node ratio predicts recurrence in papillary thyroid cancer.The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.Downregulation of LSD1 suppresses the proliferation, tumorigenicity and invasion of papillary thyroid carcinoma K1 cells.Therapeutic Outcome of Second Primary Malignancies in Patients with Well-Differentiated Thyroid Cancer.A Prospective Study Showing an Excellent Response of Patients with Low-Risk Differentiated Thyroid Cancer Who Did Not Undergo Radioiodine Remnant Ablation after Total Thyroidectomy.Surgeon training and use of radioactive iodine in stage I thyroid cancer patients.Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.Outcomes for patients with papillary thyroid cancer who do not undergo prophylactic central neck dissection.New developments in the diagnosis and treatment of thyroid cancer.Identification of Differentially Expressed Kinase and Screening Potential Anticancer Drugs in Papillary Thyroid Carcinoma.Radioactive Iodine Administration Is Associated with Persistent Related Symptoms in Patients with Differentiated Thyroid Cancer.Pediatric papillary thyroid cancer: current management challengesRole of gambogic acid and NaI131 in A549/DDP cells.Thyroid cancer in Graves' disease: is surgery the best treatment for Graves' disease?Well-differentiated thyroid carcinoma: the role of post-operative radioactive iodine administration.High versus low radioiodine activity in patients with differentiated thyroid cancer: a meta-analysis.Prophylactic central neck dissection in differentiated thyroid cancer: an assessment of the evidence.Radioiodine remnant ablation in low-risk differentiated thyroid cancer: the "con" point of view.Optimal differentiated thyroid cancer management in the elderly.Therapy-related acute myeloid leukemia following radioactive iodine treatment for thyroid cancer.
P2860
Q26765080-3F1DA586-31BC-4A30-9DF4-BD54DAC98875Q26784202-39FF4D5A-CD3D-4C84-897F-4532149F6590Q26829349-171F02C8-64F9-4818-95D6-46D1196E453EQ28071863-089100BB-805D-4419-9720-3DE6C27CC9B1Q28274899-9380AB6F-31D1-41FD-8B92-162AA21A4368Q30367068-7BD1CF62-26FD-4675-A904-90CD32E42759Q34112103-2936D238-15F9-474B-97A4-659A62C3F2EFQ34649492-8E0FAF58-8A1A-4423-A0E7-23EFA9BE5FECQ34918474-8D6357C6-5E20-43F6-9148-50A82ABDE0F2Q35201802-D8C961D4-5D3A-4B35-8D57-AD5D51479F05Q35441834-78D8ECF9-5119-41B8-BB5D-FE2590B6E701Q35537020-7840F32F-0C13-4FC6-9B9B-D657DFF90D81Q35555583-B51B78EA-CC5E-47E7-8BA8-B9C8FB2D22BAQ35961413-4233143D-06E8-4BF7-81D1-507AED26EA29Q36301401-C50F71E7-612B-4653-953D-6375CEC4BB00Q36311582-0927193D-D7B9-476B-97B6-89C3B3C9FE04Q36411194-019A725A-E9EE-48E0-A9C3-3005CCB4EC64Q36589440-4694E201-4BF3-4F2B-AF91-7BB0435A0FB5Q36602928-B3C18DEC-7913-475F-8E41-8679FE97E0B1Q36618644-3BAE576A-39D1-4C82-9AED-B55BB00EAA91Q36630446-F8E8C98D-C8DE-4671-88E4-ADD74995F104Q36666417-8681E756-F952-43B0-8D4F-277BDDD4460BQ36740912-1EFD22C2-2B94-42CF-913D-FC7F6FCAF248Q36789492-31D02D3F-1A90-4B48-900C-04AC0D51D4A7Q36811424-9C8015E7-D167-4BCE-85BD-F6DA80160C0FQ36886333-ACEA78BE-16FE-479E-ADAD-E47247170D70Q37102039-235FF68E-03CE-4A2D-8D23-0EA043FE1AB6Q37157730-AF36CA8B-4580-4597-ADD5-22684A654366Q37238757-8AC9C38C-204A-4FB1-AA24-06AA32610C17Q37293444-4AE61739-3AD4-4B18-BBF6-8C6FEFFDD7A8Q37404779-900D0231-726F-47DD-B386-1B399758D466Q37551856-509B54C2-E8B1-44B4-B5E1-ED679E945867Q37594133-616474B0-F03F-44A6-83EC-E68DB33F64D0Q38044052-841EAF3C-AB43-4113-8AE0-BFB3F451EDB6Q38063414-C3CAE6F5-BBD7-4955-90B5-449A5E8E037BQ38063535-D4CF9022-346D-42B2-B892-F50FAE271B1EQ38082409-D38A6409-7384-4CAE-98C1-B3ED5F747503Q38313318-A08DBB10-BBB5-42EA-9760-2974775C71EFQ38396892-3BCBC86F-DC09-4BFC-A0CE-1F48D7FF5BD2Q38603374-B120E280-C08C-4766-BBD3-292C716A1D43
P2860
Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Rising incidence of second can ...... ve radioactive iodine therapy.
@ast
Rising incidence of second can ...... ve radioactive iodine therapy.
@en
type
label
Rising incidence of second can ...... ve radioactive iodine therapy.
@ast
Rising incidence of second can ...... ve radioactive iodine therapy.
@en
prefLabel
Rising incidence of second can ...... ve radioactive iodine therapy.
@ast
Rising incidence of second can ...... ve radioactive iodine therapy.
@en
P2093
P2860
P356
P1433
P1476
Rising incidence of second can ...... ve radioactive iodine therapy.
@en
P2093
Ashok R Shaha
Luc G T Morris
N Gopalakrishna Iyer
R Michael Tuttle
P2860
P304
P356
10.1002/CNCR.26070
P407
P50
P577
2011-03-22T00:00:00Z